Saki Nagoshi
Overview
Explore the profile of Saki Nagoshi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
12
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yuki M, Ishimori T, Kono S, Nagoshi S, Saito M, Isago H, et al.
Sci Rep
. 2024 May;
14(1):10361.
PMID: 38710754
Chronic obstructive pulmonary disease (COPD) is a progressive disease that is characterized by chronic airway inflammation. A Japanese herbal medicine, hochuekkito (TJ-41), is prominently used for chronic inflammatory diseases in...
2.
Isago H, Mitani A, Kohno S, Nagoshi S, Ishimori T, Saito M, et al.
Biol Pharm Bull
. 2021 Jan;
44(1):39-45.
PMID: 33390548
Chronic obstructive pulmonary disease (COPD) is a systemic inflammatory disorder. It often causes weight loss, which is considered a poor prognostic factor. A Japanese herbal Kampo medicine, Hochuekkito (TJ-41), has...
3.
Watanabe K, Kage H, Nagoshi S, Toyama K, Ohno Y, Shinozaki-Ushiku A, et al.
Case Rep Oncol Med
. 2020 Apr;
2020:4201727.
PMID: 32257476
Tyrosine kinase inhibitor (TKI) combination is expected to increase in the era of precision medicine. TKI combination may be required to treat double primary cancers, each having a targetable gene,...
4.
Tagaya M, Hara K, Takahashi S, Nagoshi S, Handa H, Okano S, et al.
Int J Artif Organs
. 2018 Nov;
42(2):88-94.
PMID: 30486706
Objective:: Extracorporeal circulation devices are coated with a biocompatible polymer coating agent (BPCA) that has a hydrophilic blood-contacting layer, but hemofilters are not. We aimed to investigate the antithrombotic properties...
5.
Tagaya M, Nagoshi S, Matsuda M, Takahashi S, Okano S, Hara K
Int J Artif Organs
. 2017 Aug;
40(12):665-669.
PMID: 28777393
Purpose: Currently, the foreign surfaces of various extracorporeal circulation devices are coated with a biocompatible polymer coating agent (BPA), which creates a hydrophilic blood-contacting layer to reduce thrombogenicity, while the...